Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 4.80 is 41% above its 5-year average of 3.39, near the high end of its 5-year range (0.04–5.59).
As of the fiscal period ended Tuesday, June 30, 2026. 7.18% above its 12-month average of 4.48.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.80.
CURRENT RATIO
4.80
CURRENT RATIO AVG TTM
4.48
CURRENT RATIO AVG 3Y
4.50
CURRENT RATIO AVG 5Y
3.39
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+7.18%
CURRENT VS 3Y AVG
+6.61%
CURRENT VS 5Y AVG
+41.43%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+27.95%
vs the sector median at left
Market Cap
$634.30M
Current Ratio
5.17
TTM Avg
4.10
3Y Avg
4.28
5Y Avg
7.57
Market Cap
$638.20M
Current Ratio
16.82
TTM Avg
9.46
3Y Avg
14.12
5Y Avg
14.05
Market Cap
$656.59M
Current Ratio
8.03
TTM Avg
12.16
3Y Avg
13.50
5Y Avg
14.42
Market Cap
$657.89M
Current Ratio
1.36
TTM Avg
1.59
3Y Avg
1.59
5Y Avg
1.59
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OmniAb, Inc. (OABI) | $630.63M | 4.80 | 4.48 | 4.50 | 3.39 |
| Prime Medicine, Inc. (PRME)vs › | $632.16M | 3.05 | 5.21 | 6.01 | 5.25 |
| Zevra Therapeutics, Inc. (ZVRA)vs › | $634.30M | 5.17 | 4.10 | 4.28 | 7.57 |
| Aura Biosciences, Inc. (AURA)vs › | $638.20M | 16.82 | 9.46 | 14.12 | 14.05 |
| SOPHiA GENETICS S.A. (SOPH)vs › | $619.15M | 2.69 | 2.83 | 4.29 | 5.35 |
| Climb Bio, Inc. (CLYM)vs › | $611.57M | 31.45 | 23.29 | 26.88 | 23.21 |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $656.59M | 8.03 | 12.16 | 13.50 | 14.42 |
| Starling Oncology, Inc. (STLN)vs › | $657.89M | 1.36 | 1.59 | 1.59 | 1.59 |
| Annexon, Inc. (ANNX)vs › | $660.29M | 5.53 | 8.02 | 10.47 | 14.43 |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $597.55M | 6.06 | 2.91 | 9.31 | 9.54 |
Current Ratio
4.80
Quick Ratio
4.80
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 4.80 |
| 2026-03-31 | 4.80 |
| 2025-12-31 | 4.02 |
| 2025-09-30 | 5.00 |
| 2025-06-30 | 3.77 |
| 2025-03-31 | 4.70 |
| 2024-12-31 | 4.52 |
| 2024-09-30 | 4.62 |
| 2024-06-30 | 4.75 |
| 2024-03-31 | 4.38 |
| 2023-12-31 | 4.11 |
| 2023-09-30 | 4.26 |
| 2023-06-30 | 4.78 |
| 2023-03-31 | 5.59 |
| 2022-12-31 | 4.80 |
| 2022-09-30 | 0.04 |
| 2022-06-30 | 0.55 |
| 2022-03-31 | 0.20 |
| 2021-12-31 | 1.10 |
| 2021-09-30 | 0.40 |
| 2021-06-30 | 0.06 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 1.17 |
| 2020-09-30 | 0.00 |
